Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Oct 28:14:4501-4502.
doi: 10.2147/IDR.S344230. eCollection 2021.

"Overview of the Main Anti-SARS-CoV-2 Vaccines: Mechanism of Action, Efficacy and Safety" [Response To Letter]

Maria Teresa Mascellino  1 , Federica Di Timoteo  1 , Massimiliano De Angelis  1 , Alessandra Oliva  1
Affiliations
Comment

"Overview of the Main Anti-SARS-CoV-2 Vaccines: Mechanism of Action, Efficacy and Safety" [Response To Letter]

Maria Teresa Mascellino et al. Infect Drug Resist. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest for this communication.

Comment on

References

    1. Hasan Shuja S, Asad D, Samad Parekh A. Sinopharm: an unavoidable contender in the struggle against Covid. [Letter to the Editor, Infection and Drug Resistance 2021]. Infect Drug Resist. 2021;14:3899–3900. doi: 10.2147/IDR.S338460 - DOI - PMC - PubMed
    1. Mascellino MT, Timoteo F, De Angelis M, Oliva A. Overview of the main anti-SARS-CoV2 vaccines: mechanism of action, efficacy and safety. Infect Drug Resist. 2021;14:3459–3476. doi: 10.2147/IDR.S315727 - DOI - PMC - PubMed
    1. WHO Interim recommendations for use of the inactivated COVID-19 vaccine BIBP developed by China National Biotec Group (CNBG), Sinopharm; May 7, 2021. Available from: https://www.who.int/publications/i/item/WHO-2019-nCoV-vaccines-SAGE_reco.... Accessed October 13, 2021.
    1. Ars toscana edited by C. Silvestri, Health Regional Agency in Toscana (Italy) and C. Stasi. Available from: https://www.ars.toscana.it/2-articoli/4408-nuovo-coronavirus-vaccini-in-.... Accessed October 23, 2021.
    1. Al Kaabi N, Zhang Y, Xia S, et al. Effect of inactivated SARS-CoV-2 vaccines on symptomatic COVID-19 infection in adults: a Randomized Clinical Trial. JAMA. 2021;326(1):35–45. doi: 10.1001/jama.2021.8565 - DOI - PMC - PubMed